Daily Watch List: Arotech Corporation (NASDAQ:ARTX), Tesla Motors Inc (NASDAQ:TSLA), Intel Corporation (NASDAQ:INTC), Echo Therapeutics (NASDAQ:ECTE), Curis (NASDAQ:CRIS)


Arotech Corporation (NASDAQ:ARTX) shares decreased -2.63% in last trading session and ended the day at $1.48. ARTX Gross Margin is 28.70% and its has a return on assets of -1.60%. Arotech Corporation (NASDAQ:ARTX) quarterly performance is -42.86%.

Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and power systems and batteries for the military, commercial and medical markets. The Company operates in two divisions: Training and Simulation Division, and Power Systems Division.

Arotech Corporation’s (Nasdaq GM: ARTX) Training and Simulation Division (ATSD) announced up to $8.1 million in new contracts and awards for its Air Warfare Simulation Group. These orders include a $4 million five-year sole source award for FAAC’s air-to-air training range software, as well as significant awards to enhance its Zone Acquisition Process software, which is embedded in every U.S. Air Force fighter aircraft to assist the pilot in weapon employment. Funding associated with these new orders totals $3.4 million, with the remainder to be incrementally funded over the next five years.

On 17 September, Tesla Motors Inc (NASDAQ:TSLA) shares moved down -0.07% and was closed at $262.07. TSLA EPS growth in last 5 year was 21.50%. Tesla Motors Inc (NASDAQ:TSLA) year to date (YTD) performance is 17.83%.

Tesla Motors, Inc. designs, develops, manufactures and sells electric vehicles, electric vehicle powertrain components and stationary energy storage systems. The Company also designs, develops, manufactures and sells electric vehicle powertrain components to other automotive manufacturers.

No other car company can match Tesla Motors Inc (NASDAQ:TSLA) in terms of luxury and performance in all-electric cars — as the world learned this week, however, several competitors are trying.
Volkswagen AG VOW, Audi and Porsche divisions have unveiled concept luxury all-electric cars at the Frankfurt auto show this week. Not to be outdone, Daimler AG DAI, Mercedes-Benz said the company is also working on an electric car, according to reports.

Intel Corporation (NASDAQ:INTC) shares moved down -0.20% in last trading session and ended the day at $29.71. INTC Gross Margin is 63.50% and its has a return on assets of 12.90%. Intel Corporation (NASDAQ:INTC) quarterly performance is -7.48%.

Intel Corporation is engaged in the design and manufacture of digital technology platforms. The Company sells these platforms to original equipment manufacturers (OEMs), original design manufacturers (ODMs), and industrial and communications equipment manufacturers in the computing and communications industries.

Intel Corporation’s global investment and M&A arm Intel Capital announced that it has invested US$67 million in eight Chinese tech companies. These companies are 99cloud, AWcloud, Bluebank, Hampoo, Ninebot, Nuovo Film, Prafly Technologies and Telink Semiconductor.

Echo Therapeutics, Inc. (NASDAQ:ECTE) shares remains unchanged in last trading session and ended the day at $1.64. Its has a return on assets of -272.90%. Echo Therapeutics, Inc. (NASDAQ:ECTE) quarterly performance is -0.61%.

Echo Therapeutics, Inc. (Echo) is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market and the diabetes outpatient market. The Company offers continuous glucose monitoring, drug delivery and specialty pharmaceutical products.

Echo Therapeutics, Inc. (NASDAQ:ECTE), announced that it participate in the Rodman & Renshaw 17th Annual Global Investment Conference to be held at the St. Regis Hotel in New York City. Scott Hollander, President & Chief Executive Officer, will provide a corporate overview on Thursday, September 10 at 2:10 pm Eastern Time.

Curis, Inc. (NASDAQ:CRIS) caters to the Healthcare space. Its weekly performance is -2.60%. On the last day of trading company shares ended up at $2.62. Curis, Inc. (NASDAQ:CRIS) distance from 50-day simple moving average (SMA50) is -9.59%.

Curis, Inc. (Curis) is a biotechnology company. The Company is engaged in the development and commercialization drug candidates for the treatment of human cancers. The Company’s drug candidate, CUDC-907, is an orally available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. Curis’ product pipeline also includes CUDC-427, an orally available, small molecule antagonist of inhibitor of apoptosis (IAP) proteins.

Curis, Inc. (NASDAQ:CRIS) has received a short term rating of sell from research analysts at Zacks with a rank of 4.


Leave a Reply

Your email address will not be published. Required fields are marked *